Presentation TVT 2012 Critical Appraisal 2: MitraClip for Functional MR: Knowns, Unknowns, and Limitations Presenter: Paul Grayburn June 03, 2012 REGISTER for free or LOG IN to view this content Mitral Valve Presentation TVT 2012 Up Next Presentation TVT 2012 Design and Function/Clinical Outcomes - Sapien 3 Presenter: Josep Rodes-Cabau June 03, 2012 More slides + Presentation TVT 2012 MSCT Should Be the 'Gold Standard' for Valve Sizing Strategies Presenter: Jonathon Leipsic June 03, 2012 Presentation TVT 2012 Should CRT Be Considered Frontline Treatment for Functional Mitral Regurgitation (MR)? Presenter: Tasneem Naqvi June 04, 2012 We Recommend
Presentation TVT 2012 Design and Function/Clinical Outcomes - Sapien 3 Presenter: Josep Rodes-Cabau June 03, 2012
Presentation TVT 2012 MSCT Should Be the 'Gold Standard' for Valve Sizing Strategies Presenter: Jonathon Leipsic June 03, 2012
Presentation TVT 2012 Should CRT Be Considered Frontline Treatment for Functional Mitral Regurgitation (MR)? Presenter: Tasneem Naqvi June 04, 2012